Nowadays, CSF biomarkers tests are for use in routine clinical practice, CSF biomarker profile supports the diagnosis of AD in terms of amyloid and tau biomarkers; CSF ratio tests provide to improve the accuracy also better of an imaging test for early, rapid, easy detection and cheaper costs. This evidence concerns the gene MAPT and Alzheimer disease.